WorldCat Linked Data Explorer

http://worldcat.org/entity/work/id/413880576

Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study

Open All Close All

http://schema.org/alternateName

  • "Statement of Chairman Jon Leibowitz"@en
  • "Statement of Commissioner J. Thomas Rosch"@en
  • "How drug company pay offs cost consumers billions"@en

http://schema.org/description

  • "This study was prepared by staff from the FTC's Bureau of Competition, Bureau of Economics, and Office of Policy Planning. This study is based on patent settlement agreements filed with the FTC between January 1, 2004 and September 30, 2009 pursuant to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, 117 Stat. 2066, codified in relevant part at 42 U.S.C. & 1395w-101 note (section 110), 21 U.S.C. & 355 note (sections 1111-1118), 21 U.S.C. & 355(j)(5) (section 1102). Staff identified agreements in which restrictions on generic entry were combined with compensation from the brand to the generic. The FTC has challenged some of these agreements as violating the antitrust laws, but the agency lacks sufficient resources to investigate and litigate the legality of all of these agreements."

http://schema.org/name

  • "Pay-for-delay how drug company pay-offs cost consumers billions : an FTC staff study"
  • "Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study"@en
  • "Pay-for-delay : how drug company pay-offs cost consumers billions"@en